ACADIAN ASSET MANAGEMENT LLC

Position in RXST — RxSight, Inc.

CIK 916542 Boston, MA

Position in RXST

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$6,277,822

+$1,934,475 QoQ

Shares Held

1,019,127

+144.5% QoQ

Ownership

2.46%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

ACADIAN ASSET MANAGEMENT LLC holds $1,019,768,081 across 54 Medical Devices names. RXST ranks #20 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	3,222,118	$330,814,855
2	SYK	Stryker Corp	449,052	$147,553,996
3	BSX	Boston Scientific Corp	1,495,140	$93,820,035
4	MDT	Medtronic plc	828,643	$71,801,915
5	EW	Edwards Lifesciences Corp	818,164	$65,518,573
6	PODD	Insulet Corp	256,584	$53,841,586
7	INMD	InMode Ltd.	2,593,203	$35,475,017
8	DXCM	Dexcom Inc	463,647	$29,117,031

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,277,822	1,019,127	+144.5%	Shares	Defined	2026-05-13
2025-12-31	$4,343,347	416,828	+49.4%	Shares	Defined	2026-02-10
2025-09-30	$2,507,544	278,926	+22558.5%	Shares	Defined	2025-11-13
2025-06-30	$16,003	1,231	-49.6%	Shares	Defined	2025-08-07
2024-06-30	$146,874	2,441	-80.3%	Shares	Defined	2024-08-06
2024-03-31	$637,580	12,361	-63.7%	Shares	Defined	2024-05-10
2023-12-31	$1,372,210	34,033	-79.2%	Shares	Defined	2024-02-13
2023-09-30	$4,564,505	163,661	-2.0%	Shares	Defined	2023-11-13
2023-06-30	$4,807,929	166,942	+1072.3%	Shares	Defined	2023-08-07
2023-03-31	$237,523	14,240	+783.9%	Shares	Defined	2023-05-11
2022-09-30	$19,332	1,611	—	Shares	Defined	2022-11-14
No filing history on record for this holder in this stock.